225 related articles for article (PubMed ID: 17340546)
1. [The participation experiences of localized prostate cancer patients in the treatment decision-making process].
Chien CH; Chuang CK; Liu KL; Liu HE
Hu Li Za Zhi; 2007 Feb; 54(1):35-42. PubMed ID: 17340546
[TBL] [Abstract][Full Text] [Related]
2. Treatment decision-making strategies and influences in patients with localized prostate carcinoma.
Gwede CK; Pow-Sang J; Seigne J; Heysek R; Helal M; Shade K; Cantor A; Jacobsen PB
Cancer; 2005 Oct; 104(7):1381-90. PubMed ID: 16080181
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F;
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680
[TBL] [Abstract][Full Text] [Related]
4. Current decision-making in prostate cancer therapy.
Cox J; Amling CL
Curr Opin Urol; 2008 May; 18(3):275-8. PubMed ID: 18382237
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer treatment decisions: a focus group exploration.
O'Rourke ME; Germino BB
Oncol Nurs Forum; 1998; 25(1):97-104. PubMed ID: 9460777
[TBL] [Abstract][Full Text] [Related]
6. Treatment decision-making in localized prostate cancer: why patients chose either radical prostatectomy or external beam radiation therapy.
Ihrig A; Keller M; Hartmann M; Debus J; Pfitzenmaier J; Hadaschik B; Hohenfellner M; Herzog W; Huber J
BJU Int; 2011 Oct; 108(8):1274-8. PubMed ID: 21410634
[TBL] [Abstract][Full Text] [Related]
7. Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE.
Marr PL; Elkin EP; Arredondo SA; Broering JM; DuChane J; Carroll PR
J Urol; 2006 Apr; 175(4):1326-31. PubMed ID: 16515991
[TBL] [Abstract][Full Text] [Related]
8. Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote.
Denberg TD; Melhado TV; Steiner JF
Cancer; 2006 Aug; 107(3):620-30. PubMed ID: 16802287
[TBL] [Abstract][Full Text] [Related]
9. A novel computer based expert decision making model for prostate cancer disease management.
Richman MB; Forman EH; Bayazit Y; Einstein DB; Resnick MI; Stovsky MD
J Urol; 2005 Dec; 174(6):2310-8. PubMed ID: 16280831
[TBL] [Abstract][Full Text] [Related]
10. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
[TBL] [Abstract][Full Text] [Related]
11. Evidence-based patient choice: a prostate cancer decision aid in plain language.
Holmes-Rovner M; Stableford S; Fagerlin A; Wei JT; Dunn RL; Ohene-Frempong J; Kelly-Blake K; Rovner DR
BMC Med Inform Decis Mak; 2005 Jun; 5():16. PubMed ID: 15963238
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.
Kulkarni GS; Lockwood G; Evans A; Toi A; Trachtenberg J; Jewett MA; Finelli A; Fleshner NE
Cancer; 2007 Jun; 109(12):2432-8. PubMed ID: 17497649
[TBL] [Abstract][Full Text] [Related]
13. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer.
Sommers BD; Beard CJ; D'Amico AV; Dahl D; Kaplan I; Richie JP; Zeckhauser RJ
Cancer; 2007 Nov; 110(10):2210-7. PubMed ID: 17893907
[TBL] [Abstract][Full Text] [Related]
14. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
Frank SJ; Pisters LL; Davis J; Lee AK; Bassett R; Kuban DA
J Urol; 2007 Jun; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
[TBL] [Abstract][Full Text] [Related]
15. Impact of a multi-disciplinary patient education session on accrual to a difficult clinical trial: the Toronto experience with the surgical prostatectomy versus interstitial radiation intervention trial.
Wallace K; Fleshner N; Jewett M; Basiuk J; Crook J
J Clin Oncol; 2006 Sep; 24(25):4158-62. PubMed ID: 16943531
[TBL] [Abstract][Full Text] [Related]
16. Choose wisely: therapeutic decisions and quality of life in patients with prostate cancer.
O'Rourke ME
Clin J Oncol Nurs; 2007 Jun; 11(3):401-8. PubMed ID: 17623624
[TBL] [Abstract][Full Text] [Related]
17. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.
Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR
J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537
[TBL] [Abstract][Full Text] [Related]
18. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
[TBL] [Abstract][Full Text] [Related]
19. Treatment options for prostate cancer: evaluating the evidence.
Bhatnagar V; Kaplan RM
Am Fam Physician; 2005 May; 71(10):1915-22. PubMed ID: 15926407
[TBL] [Abstract][Full Text] [Related]
20. The current state of brachytherapy nomograms for patients with clinically localized prostate cancer.
Nguyen CT; Zelefsky MJ; Kattan MW
Cancer; 2009 Jul; 115(13 Suppl):3121-7. PubMed ID: 19544540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
